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Objectives This study sought to test the effects of rostral fluid displacement from the legs on transpharyngeal resistance
(Rph), minute volume of ventilation (Vmin), and partial pressure of carbon dioxide (PCO2) in men with heart failure
(HF) and either obstructive (OSA) or central sleep apnea (CSA).
Background Overnight rostral fluid shift relates to severity of OSA and CSA in men with HF. Rostral fluid displacement may
facilitate OSA if it shifts into the neck and increases Rph, because pharyngeal obstruction causes OSA. Rostral
fluid displacement may also facilitate CSA if it shifts into the lungs and induces reflex augmentation of ventila-
tion and reduces PCO2, because a decrease in PCO2 below the apnea threshold causes CSA.
Methods Men with HF were divided into those with mainly OSA (obstructive-dominant, n  18) and those with mainly CSA
(central-dominant, n  10). While patients were supine, antishock trousers were deflated (control) or inflated for
15 min (lower body positive pressure [LBPP]) in random order.
Results LBPP reduced leg fluid volume and increased neck circumference in both obstructive- and central-dominant
groups. However, in contrast to the obstructive-dominant group in whom LBPP induced an increase in Rph, a de-
crease in Vmin, and an increase in PCO2, in the central-dominant group, LBPP induced a reduction in Rph, an in-
crease in Vmin, and a reduction in PCO2.
Conclusions These findings suggest mechanisms by which rostral fluid shift contributes to the pathogenesis of OSA and CSA
in men with HF. Rostral fluid shift could facilitate OSA if it induces pharyngeal obstruction, but could also facili-
tate CSA if it augments ventilation and lowers PCO2. (J Am Coll Cardiol 2013;61:1157–66) © 2013 by the
American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.10.055Sleep apnea occurs in approximately 50% of patients with
heart failure (HF), where it is associated with increased
mortality (1–3). There are 2 types of sleep apnea: obstructive
(OSA) and central (CSA).
OSA is due to repetitive pharyngeal collapse during sleep
that occurs when sleep-related loss in pharyngeal dilator
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See page 1167
Pharyngeal narrowing can be due to fatty deposition in the
neck or fluid retention in the pharyngeal mucosa. Increases
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Fluid Shift and Pharyngeal Resistance in Heart Failure March 19, 2013:1157–66in mucosal fluid volume around
the pharynx may reduce pharyn-
geal cross-sectional area and in-
crease transpharyngeal resistance
(Rph) (5). This may explain why
OSA is more prevalent in pa-
tients with fluid retention, such as
HF, than in the general popula-
tion, despite lower body weight
(1,6). It has also been shown that
a reduction in overnight rostral
fluid redistribution from the legs
into the neck due to compression
stockings during the daytime can
attenuate OSA (7).
CSA is more prevalent in
those with HF than in the gen-
eral population (8), and is found
predominantly in men for reasons
yet to be elucidated (1). CSA dur-
ing sleep occurs when partial pres-
sure of carbon dioxide (PCO2)
falls below the apnea threshold
due to hyperventilation (9). Several
factors can contribute to hyperven-
tilation and hypocapnia in HF pa-
tients with CSA, including respi-
ratory control system instability due
to increased chemosensitivity (10),
pulmonary congestion (11), and
arousals from sleep (9). Low car-
diac output and prolonged circu-
lation time might also play a role
in the pathophysiology of CSA
in HF, but these appear to con-
tribute more to causing prolongation of the periodic breath-
ing cycle than to precipitating central respiratory events
(12,13). Unlike obstructive apneas and hypopneas, central
apneas and hypopneas can sometimes be observed in HF
patients with CSA while awake as part of Cheyne-Stokes
respiration (14,15). Fluid retention may also play an impor-
tant role in the pathogenesis of CSA by provoking hyper-
ventilation and hypocapnia partly as a result of pulmonary
irritant receptor stimulation by pulmonary congestion (11).
In HF patients, PCO2 is inversely proportional to pulmo-
ary capillary wedge pressure (16), which is higher in
atients with CSA than in those without CSA (12). In HF
atients, nocturnal PCO2 is also related inversely, and the
requency of central events, directly, to the amount of fluid
isplaced rostrally from the legs overnight (17). Under such
onditions, increases in ventilation can decrease PCO2
below the apnea threshold and trigger central apnea (9,18).
Because augmented central respiratory drive stimulates both
respiratory pump and pharyngeal dilator muscles (19), it is
expected that the fluid shift into the lungs of HF patients
Abbreviations
and Acronyms
AHI  apnea-hypopnea
index
BP  blood pressure
CSA  central sleep apnea
eGFR  estimated
glomerular filtration rate
HF  heart failure
HR  heart rate
LBPP  lower body positive
pressure
LVEF  left ventricular
ejection fraction
LFV  leg fluid volume
NC  neck circumference
NT-proBNP  N-terminal of
pro–B-type natriuretic
peptide
NYHA  New York Heart
Association
OSA  obstructive sleep
apnea
PCO2  partial pressure of
carbon dioxide
PtcCO2  transcutaneous
PCO2
Rph  transpharyngeal
resistance
SaO2  oxyhemoglobin
saturation
Vmin  minute volume of
ventilationmay cause both an increase in ventilation and a lowering ofRph, both of which will facilitate a drop in PCO2. These
bservations suggest that fluid retention also plays a role in
he pathogenesis of CSA. Fluid retention may explain, in part,
hy both types of sleep apnea are more common in HF
atients than in the general population, why both types of sleep
pnea can coexist in the same HF patient, and why the
redominant type can change over time (20–22).
Our group previously showed in healthy, nonobese sub-
ects that applying lower body positive pressure (LBPP) via
edical antishock trousers causes rostral fluid displacement
rom the legs, which results in increases neck circumference
NC) and Rph, decreases in pharyngeal caliber, and increases
in pharyngeal collapsibility (5,23,24). The effects of rostral
fluid shift from the legs by LBPP on NC, ventilation,
PCO2, and Rph in patients with HF have yet to be
determined. We, therefore, undertook the present study to
test the hypotheses that the predominant effect of rostral
fluid displacement from the legs by LBPP will be to induce
pharyngeal obstruction in HF patients with OSA, as man-
ifested by an increase Rph, a reduction in minute volume of
ventilation (Vmin), and an increase in PCO2, whereas in
those with CSA, its predominant effect will be to augment
respiratory drive as manifested by an increase in Vmin,
ccompanied by reductions in Rph and PCO2.
ethods
ubjects. Inclusion criteria were men 18 to 85 years of age
ith HF due to ischemic or nonischemic dilated cardiomy-
pathy for 6 months, left ventricular ejection fraction
LVEF) 45%, in New York Heart Association (NYHA)
lasses I to III, and who were clinically stable without
edication changes for 3 months. Exclusion criteria were
cute decompensated HF, treated sleep apnea, tonsillar
ypertrophy, and unstable angina, myocardial infarction, or
ardiac surgery within the previous 3 months. Subjects’
haracteristics and medications were recorded before exper-
ments. Echocardiography, including assessment of mitral
egurgitation grades from 0 (none) to 4 (severe), estimated
lomerular filtration rate (eGFR), and N-terminal of pro–
-type natriuretic peptide (NT-proBNP) levels were as-
essed within 3 months before the experiments. The Mal-
ampati Score was assessed at the time of experiments (25).
he protocol was approved by the Research Ethics
oards of University Health Network and Mount Sinai
ospital, and all subjects provided written consent before
articipation.
olysomnography. All subjects underwent overnight poly-
omnography using standard techniques and scoring criteria
or sleep stages and arousals (26,27). Thoracoabdominal
otion was monitored by respiratory inductance plethys-
ography, and nasal airflow by nasal pressure cannulas.
xyhemoglobin saturation (SaO2) was monitored by oxim-
etry. Apneas and hypopneas were defined as90% and 50%
to 90% reduction in tidal volume from baseline, respectively,
lasting 10 s, and were classified as obstructive or central as
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March 19, 2013:1157–66 Fluid Shift and Pharyngeal Resistance in Heart Failurepreviously described (1). The frequency of apneas and
hypopneas per hour of sleep (i.e., apnea-hypopnea index
[AHI]) was quantified. Signals were recorded on a comput-
erized sleep recording system (Sandman, Nellcor Puritan
Bennett Ltd., Ottawa, Ontario, Canada) and scored by
technicians blinded to the experimental data. Subjects were
divided into an obstructive-dominant group (50% of
events obstructive) and a central-dominant group (50% of
events central).
Lower body positive pressure, leg fluid volume, and neck
circumference. With subjects lying supine, deflated medi-
cal antishock trousers (MAST III-AT, David Clark, Inc.,
Worcester, Massachusetts) were applied to both legs from
the ankles to the upper thighs at the beginning of the
baseline period. LBPP was applied by rapidly inflating the
trousers to 40 mm Hg for 15 min, after which the trousers
were deflated. We used this technique because we have
shown that it is safe, induces rostral fluid shift, and unlike
head-down tilting, does not alter posture, and therefore,
does not cause posture-related alterations in upper airway
geometry that could confound interpretation of the influ-
ence of fluid shifts on Rph. Total fluid volume of both legs
was measured using a bioimpedance spectrum analyzer
(model 4200, Xitron Technologies, Inc., San Diego, Cali-
fornia) (5,7,17,23,24,28–30). Two pairs of electrodes were
applied to each leg: 1 pair to the upper thigh and the other
to the ankle. This well-validated technique (31,32) uses
impedance to electrical current within a body segment to
measure its fluid content. A strain gauge plethysmograph
(EC4, D.E. Hokanson, Inc., Bellevue, Washington) (33)
was then wrapped around the neck above the cricothyroid
cartilage and secured in place with tape to measure changes
in NC during the experiments (5,23,24).
Pharyngeal resistance. After application of local anesthe-
sia using a 10% lidocaine spray to the nares and the
oropharynx, 2 open catheters were introduced into 1 nostril.
The first catheter was advanced to the back of the nose, then
withdrawn 0.5 cm to the choanae for measurement of
nasopharyngeal pressure. The second catheter was advanced
beyond the soft palate and base of the tongue to as far as the
subjects could tolerate without gagging or discomfort, or to
18 cm from the nares, whichever was reached first, for
measurement of hypopharyngeal pressure (5,34,35). The
catheters were secured with tape to the upper lip and
remained in place throughout the experiments. Each catheter
was connected to a differential pressure transducer (Validyne
MP45, Validyne Engineering, Northridge, California). These
pressures were referenced to pressure measured inside a face
mask. Flow was measured using a pneumotachograph (Hans
Rudolph Model 4700, Hans Rudolph, Inc., Kansas City, Mis-
souri) connected to a tightly fitting face mask. Pressure and
flow signals were amplified and fed through an analog-to-
digital converter, and then stored in a computer for later
analysis. Transpharyngeal pressure gradient was calculated as
the difference between hypopharyngeal and nasopharyngeal
pressures, and Rph was determined by dividing this by simul- dtaneously measured airflow (35). Two to three milliliters of
compressed air were injected through the proximal port of the
catheters to clear secretions from the catheter tips as required.
Blood pressure, heart rate, PCO2, and minute volume of
entilation. Systolic and diastolic blood pressures (BP)
ere recorded every 5 min using an automated oscillatory
evice applied to the upper arm (BPM-200: BpTRU
edical Devices Ltd., Coquitlam, British Colombia, Can-
da). Heart rate (HR) was measured during BP measure-
ents. Transcutaneous PCO2 (PtcCO2) was recorded with
a capnograph (Microgas 7650, Linde, Basel, Switzerland)
placed on the surface of the chest and calibrated against test
gases at the beginning of each study. Tidal volume and
respiratory rate were monitored continuously by a respira-
tory inductance plethysmograph (Respitrace, Ambulatory
Monitoring, Inc., Ardsley, New York) calibrated against a
spirometer. Vmin was calculated from the averaged tidal
volume multiplied by respiratory rate per minute.
Experimental protocol. A randomized double crossover
design was employed. Experiments were performed with
subjects awake, and lying supine with their head and neck in
the neutral position supported by a small pillow. Subjects
were instructed to breathe normally through their noses.
Following a 5-min baseline period, subjects were ran-
domized to either LBPP or a control period for the next 15
min. Subjects were then seated upright for 30 min as a
washout period. They then underwent a second baseline
period, after which they were crossed over to the other arm
of the study for 15 min. To ensure subjects remained awake
throughout studies, the sleep and/or wake state was assessed
by electroencephalogram, and an electrooculogram and
submandibular electromyogram were recorded. Measure-
ments of leg fluid volume (LFV), BP, HR, Vmin, and
PtcCO2 were made at the end of each baseline period, and
at 5-min intervals during LBPP and control periods.
Data analysis. During each 30-s period, the greatest trans-
pharyngeal pressure gradient and corresponding airflow
were determined to calculate Rph. Then, the Rph values
rom each 30-s period were averaged over 5 min of the
aseline period and 15 min of the LBPP and control
eriods. NC and Vmin were averaged over the 5-min
baseline period and the 15-min LBPP and control periods.
For LFV, BP, HR, and PtcCO2, values obtained at the end
f each baseline, the LBPP and control periods were used
or analysis.
Data are presented as mean  SD or median (interquar-
ile range), unless indicated otherwise. For comparisons of
ubjects’ characteristics between obstructive- and central-
ominant groups, Student t-test for normally distributed
ontinuous variables, Mann-Whitney U test for non-
ormally distributed variables, and chi-square or Fisher’s
xact test for nominal variables were used. Within each
roup, 2-way repeated-measures analysis of variance, fol-
owed by a post hoc analysis with Bonferroni correction for
ultiple comparisons, was used to compare values obtained
uring the baseline and either LBPP or control periods.
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Fluid Shift and Pharyngeal Resistance in Heart Failure March 19, 2013:1157–66Changes () from baseline to the LBPP period (i.e., values
during LBPP  values at baseline) were then compared
between the obstructive- and central-dominant groups us-
ing analysis of covariance to take into account any potential
corresponding changes during the control period. Relation-
ships between variables were examined by Pearson correla-
tion coefficient. A 2-sided p value 0.05 was considered
significant. Statistical analyses were performed by SPSS
version 17.0 (SPSS Inc., Chicago, Illinois).
Results
Characteristics of the subjects. We recruited 28 men with
HF: 18 in the obstructive-dominant group and 10 in the
central-dominant group. Characteristics of these subjects
are shown in Table 1. The central-dominant group had a
significantly greater degree of mitral regurgitation, higher
NT-proBNP level, and right ventricular systolic pressure, as
well as shorter mitral inflow deceleration time compared
with the obstructive-dominant group. However, there were
no significant differences in other characteristics between
the 2 groups. At the time of the experiments, none of the
subjects had physical findings indicative of pulmonary
edema. All subjects remained awake during studies, and
neither periodic breathing nor Cheyne-Stokes respiration
was observed in any of them during this time.
Effects of LBPP within groups. In the obstructive-
dominant group, all variables remained stable during the
control period compared with baseline (Table 2). Similarly,
baseline values before the LBPP period did not differ
Characteristics of the SubjectsTable 1 Characteristics of the Subjects
Characteristics Obstructive
Age, yrs 5
Height, cm 17
Weight, kg 9
BMI, kg/m2 3
Neck circumference, cm 4
AHI, events/h 3
Mallampati score
Ischemic pathogenesis
NYHA class
LVEF, % 2
MR grade
Mitral E/A velocity ratio*
Deceleration time, ms 20
Right ventricular systolic pressure, mm Hg† 3
NT-proBNP, ng/l 163
eGFR, ml/min/1.73 m2 7
Beta-blockers
ACE inhibitors/AT2 antagonists
Spironolactone
Thiazide or loop diuretics
Values are mean  SD or n (%). *Data unavailable in 3 of the obstruc
†Data unavailable in 1 subject in each group due to technical difficul
ACE  angiotensin-converting enzyme; AHI  apnea-hypopnea inde
glomerular filtration rate; LVEF left ventricular ejection fraction; NT-proBNP
Association.significantly from baseline values before the control period.
However, during the LBPP period, LFV decreased and NC
increased significantly, and those changes were significantly
greater than those during the control period (p  0.001 for
both). In addition, during the LBPP period, Rph increased,
min decreased, and PCO2 increased significantly compared
ith baseline, and these changes were significantly greater
han those during the control period (p 0.002, p 0.003,
nd p  0.046, respectively).
In the central-dominant group, all variables also remained
table during the control period, and baseline values before
he LBPP period did not differ significantly from baseline
alues before the control period (Table 2). During the
BPP period, LFV decreased and NC increased signifi-
antly, and those changes were significantly greater than
hose during the control period (p  0.001 and p  0.004,
respectively). During the LBPP period, Rph decreased, Vmin
increased, and PCO2 decreased significantly compared with
baseline, and these changes were significantly greater than
those during the control period (p  0.005, p  0.005, and
p  0.001, respectively). No subject experienced any dys-
pnea or other side effects during the experiments.
Comparisons between obstructive- and central-dominant
groups. As shown in Table 3, changes from the control to
the LBPP period for systolic and diastolic BP, HR, LFV, and
NC did not differ between the 2 groups. However, there were
contrasting responses of Rph, Vmin, and PtcCO2 to LBPP
between the 2 groups: Rph increased, Vmin decreased, and
tcCO2 increased in the obstructive-dominant group,
nant (n  18) Central-Dominant (n  10) p Value
10.7 60.2 12.3 0.104
9.3 171.0 5.5 0.250
24.9 91.0 15.5 0.416
6.5 31.1 5.1 0.770
4.0 42.3 2.4 0.892
21.7 43.8 26.1 0.355
.0) 2.5 (1.3) 0.555
9) 5 (50) 0.698
.3) 3.0 (1.0) 0.226
9.1 31.6 8.3 0.643
.0) 3.0 (1.3) 0.002
0.4 1.3 0.6 0.080
27.3 162.3 28.2 0.001
6.3 39.1 8.6 0.012
1673.8 3883.5 2354.5 0.007
21.0 69.2 20.8 0.544
4) 10 (100) 1.000
9) 10 (100) 0.524
4) 3 (30) 0.453
7) 7 (70) 0.856
inant and 4 of the central-dominant groups due to atrial fibrillation.
angiotensin-2 receptor; BMI  body mass index; eGFR  estimated-Domi
2.7
4.8
8.2
1.8
2.5
5.2
3.0 (1
7 (3
2.0 (1
9.9
0 (2
1.0
8.3
1.0
6.0
4.3
17 (9
16 (8
8 (4
12 (6
tive-dom
ties.
x; AT2  N-terminal pro–B-type natriuretic peptide; NYHA  New York Heart
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March 19, 2013:1157–66 Fluid Shift and Pharyngeal Resistance in Heart Failurewhereas Rph decreased, Vmin increased, and PtcCO2 de-
reased significantly in the central-dominant group (Fig. 1).
elationships between LFV during LBPP and other
ariables. In the obstructive-dominant group, the greater
he amount of fluid displaced from the legs during LBPP,
he greater the increase in NC and Rph during LBPP
(Figs. 2A and 3A, respectively). However, there was no
significant relationship between LFV and either Vmin or
PtcCO2 during LBPP (Figs. 4A and 5A, respectively).
In the central-dominant group, there was no significant
relationship betweenNC andLFV during LBPP (Fig. 2B).
However, the greater the decrease in LFV during LBPP,
the more pronounced the decrease in Rph, the greater the
ncrease in Vmin, and the greater the decrease in PtcCO2
(Figs. 3B, 4B, and 5B, respectively).
Relationship between Rph during LBPP and NT-
proBNP levels. In the obstructive-dominant group, there
was no significant relationship between Rph during LBPP
Changes From Baseline to Control or LBPP Period Within Each GroTable 2 Changes From Baseline to Control or LBPP Period Wit
Baseline Control
Obstructive-dominant (n  18)
Systolic BP, mm Hg 121.7 24.9 121.1
Diastolic BP, mm Hg 75.5 13.7 74.8
Heart rate, beats/min 68.1 12.1 67.2
LFV, l 9.97 2.71 9.94
NC, % 0 0.03
Rph, cmH2O/l/s 5.50 3.89 5.21
Vmin, l 7.5 1.4 7.7
PtcCO2, mm Hg 40.2 4.6 40.3
SaO2, % 97.3 1.0 97.4
Central-dominant (n  10)
Systolic BP, mm Hg 112.2 19.2 114.0
Diastolic BP, mm Hg 70.3 12.2 69.6
Heart rate, beats/min 67.1 11.3 66.4
LFV, ml 8.07 1.46 8.07
NC, % 0 0.07
Rph, cmH2O/l/s 4.69 2.97 5.13
Vmin, l 8.1 2.6 7.9
PtcCO2, mm Hg 37.6 6.7 38.5
SaO2, % 97.7 1.1 97.9
Values are mean  SD. *p values for (time)*(treatment) interaction. †p  0.05 versus baseline.
BP  blood pressure; LBPP  lower body positive pressure; LFV  leg fluid volume; NC  neck
SaO2  oxyhemoglobin saturation; Vmin  minute volume of ventilation.
Comparisons of Responses to LBPP BetweenObstructive-D minant and Central-Dominant GroupsTable 3 C p risons of Responses to LBPP BetweenObstructive-Dominant and Central-Dominant Groups
Obstructive-Dominant
(n  18)
Central-Dominant
(n  10) p Value
Systolic BP, mm Hg 2.9 8.1 1.7 4.6 0.526
Diastolic BP, mm Hg 0.8 4.9 1.8 6.3 0.811
Heart rate, beats/min 0.7 3.9 0.7 1.8 0.849
SaO2, % 0.1 0.1 0.1 0.4 0.671
LFV, ml 260.0 104.5 249.0 88.8 0.489
NC, % 0.57 0.42 0.50 0.36 0.781T
Values are mean  SD.
Abbreviations as Table 2.nd NT-proBNP levels (r0.285, p 0.251). In addition,
T-proBNP levels did not correlate with Vmin or PtcCO2
during LBPP (r 0.118, p 0.640, and r0.284, p 0.253,
respectively).
However, in the central-dominant group, there was a
strong inverse relationship between Rph during LBPP and
T-proBNP levels (r  0.894, p  0.001). In addition,
T-proBNP levels correlated directly with Vmin and
nversely with PtcCO2 during LBPP (r  0.883, p 
0.001, and r  0.715, p  0.020, respectively).
Discussion
This study provides several insights relevant to the patho-
genesis of OSA and CSA in men with HF. First, in the
obstructive-dominant group, application of LBPP, which
displaced 260 ml of fluid from the legs, increased NC and
induced a degree of upper airway obstruction, reflected by
an increase in Rph. This was a physiologically significant
effect because it was sufficient to reduce Vmin and increase
PtcCO2. Second, in the central-dominant group, LBPP
displaced a similar amount of fluid from the legs and
resulted in an increase in NC similar to that in the
obstructive-dominant group. However, in contrast to the
obstructive-dominant group, LBPP induced a reduction in
Rph accompanied by an increase in Vmin. These changes
were physiologically significant because they were sufficient
to reduce PtcCO2 by 1.4 mm Hg; they might also be
linically significant because a decrease of this magnitude
an induce central apnea during sleep in HF patients (9,18).
ach Group
Baseline LBPP Period p Value*
122.7 25.4 125.6 27.4 0.103
77.0 15.1 77.8 15.6 0.311
67.6 12.0 68.3 13.0 0.217
9.93 2.70 9.67 2.64† 0.001
0 0.57 0.42† 0.001
3.82 1.87 7.02 5.19† 0.002
9.2 3.3 8.9 3.3† 0.003
39.8 3.3 40.5 5.8† 0.046
97.4 0.8 97.5 0.8 0.579
115.1 18.4 116.8 18.0 0.944
71.3 11.2 72.8 13.2 0.343
65.5 10.0 64.8 9.8 0.934
8.05 1.38 7.80 1.34† 0.001
0 0.50 0.36† 0.004
5.96 3.49 4.88 2.60† 0.005
7.6 2.8 8.7 3.0† 0.005
39.4 5.8 38.0 5.7† 0.001
97.7 0.9 97.7 0.9 1.000
ference; PtcCO2, transcutaneous partial pressure of carbon dioxide; Rph  pharyngeal resistance;uphin E
Period
25.4
12.8
11.2
2.71
0.46
3.62
1.4
4.5
0.9
20.7
11.4
10.1
147
0.39
2.60
2.0
6.2
1.2hese data suggested that a portion of the fluid displaced
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Fluid Shift and Pharyngeal Resistance in Heart Failure March 19, 2013:1157–66from the legs shifted into the lungs, stimulated pulmonary
irritant receptors, and increased central respiratory drive.
The observation that hyperventilation was accompanied by
a decrease in Rph indicated that such increased central
espiratory drive activated both the inspiratory pump and
haryngeal dilator muscles simultaneously (19). Taken to-
ether, these data suggested that in patients with HF,
ostral fluid displacement from the legs in obstructive-
ominant patients behaved in a way that would predispose
o upper airway obstruction during sleep, because it in-
reased Rph, which taken to the extreme, would result in
omplete pharyngeal occlusion. In contrast, in the central-
ominant group, such fluid displacement behaved in a way
Figure 2
Relationship Between NC
and LFV in Response to LBPP in the
Obstructive- and Central-Dominant Groups
In the obstructive-dominant group (A), the greater the reduction in leg fluid vol-
ume (LFV) during LBPP, the greater the increase in neck circumference (NC).
However, in the central-dominant group (B), there was no significant relation-
ship between LFV and NC during LBPP. LFV  change in leg fluid volume;
NC  change in neck circumference; other abbreviations as in Figure 1.Figure 1 Influence of Lower LBPP on Rph and Vmin in
the Obstructive- and Central-dominant Groups
In response to the lower body positive pressure (LBPP) in the obstructive-domi-
nant group, transpharyngeal resistance (Rph) (A) increased, minute volume of
ventilation (Vmin) (B) decreased, and transcutaneous PCO2 (PtcCO2) (C)
increased, whereas in the central-dominant group, Rph decreased, Vmin
increased, and PtcCO2 decreased. Thus, LBPP caused opposite effects on Rph,
PtcCO2, and Vmin in the obstructive- and central-dominant groups. PCO2  par-
tial pressure of carbon dioxide; PtcCO2  change in transcutaneous PCO2;
Rph, change in transpharyngeal resistance; Vmin  change in minute volume
of ventilation.hat would augment respiratory drive and lower PCO2, thus
t
i
(
i
u
i
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because taken to the extreme, PCO2 would fall below the
apnea threshold. Accordingly, these findings extended those
of our previous study in men with HF (17), by providing
evidence of a differential response to rostral fluid shift that
could predispose to OSA by inducing upper airway obstruc-
tion on the one hand (4,36) or to CSA by augmenting
respiratory drive (37) on the other.
Compared with age- and weight-matched controls, OSA
patients have higher pharyngeal resistance, and greater
compliance and collapsibility during both wakefulness and
sleep (38–41). Pharyngeal narrowing and increased Rph can
be due to an increase in surrounding soft tissue as a result of
Figure 3
Relationship Between Rph and
LFV in Response to LBPP in the
Obstructive-and Central-Dominant Groups
In the obstructive-dominant group (A), the greater the reduction in LFV during
LBPP, the greater the increase in Rph. In contrast, in the central-dominant
group (B), the greater the reduction in LFV during LBPP, the greater the reduc-
tion in Rph. Abbreviations as in Figures 1 and 2.muscular hypertrophy, inflammation, and fat or fluid accu-mulation in the peripharyngeal tissues (4,36). The latter
may be amenable to manipulation. For example, adminis-
tration of systemic or topical vasoconstrictor agents that
reduce peripharyngeal blood (i.e., fluid) volume to cats and
humans increases pharyngeal cross-sectional area and re-
duces Rph (42,43). In addition, the jugular veins lie adjacent
o the lateral pharyngeal walls, and their distension can
ncrease NC. Because NC generally correlates with AHI
44), outward expansion of the neck may be accompanied by
nward displacement of the lateral pharyngeal walls, partic-
larly behind the ramus of the mandible, which may
mpinge on the pharynx.
Our group previously showed that rostral fluid displace-
ent from the legs by applying LBPP increases NC and Rph
Figure 4
Relationship Between Vmin and
LFV in Response to LBPP in the
Obstructive- and Central-Dominant Groups
In the obstructive-dominant group (A), there was no significant relationship
between LFV and Vmin during LBPP. However, in the central-dominant group
(B), the greater the reduction in LFV during LBPP, the greater the increase in
V . Abbreviations as in Figures 1 and 2.min
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its collapsibility in healthy, nonobese subjects (5,23,24).
There was also a strong relationship between the amount of
fluid displaced spontaneously from the legs overnight and
the overnight increase in NC and severity of OSA in
nonobese, otherwise healthy men, in men with HF, and in
subjects with hypertension or renal failure (17,28–30).
Furthermore, the observation in both men with OSA and in
patients with chronic venous insufficiency that use of venous
compression stockings during the day reduced LFV, over-
night LFV, and the AHI by approximately 35% provides
proof that nocturnal rostral fluid shift plays a causative role
in OSA (7). Bucca et al. (45) also reported, in an uncon-
Figure 5
Relationship Between PtcCO2
and LFV in Response to LBPP in
the Obstructive- and Central-Dominant Groups
In the obstructive-dominant group (A), there was no significant relationship
between LFV and PtcCO2 during LBPP. However, in the central-dominant
group (B), the greater the decrease in LFV during LBPP, the greater the
decrease in PtcCO2. Abbreviations as in Figures 1 and 2.trolled trial, that diuretic therapy increased pharyngealcaliber and reduced AHI in patients with decompensated
diastolic HF. The observations from the present study that
rostral fluid shift from the legs due to LBPP induces
increases in both NC and Rph in a dose-response manner in
obstructive-dominant patients with HF provides evidence
that one of the mechanisms through which rostral fluid
displacement could cause OSA is by increasing peripharyn-
geal fluid accumulation and pharyngeal obstruction.
HF predisposes to CSA by provoking hypocapnia partly
as a result of respiratory control system instability due to
increased chemosensitivity (10), arousals from sleep (9),
possibly increased circulation time, and nonchemical pul-
monary irritant receptor stimulation by pulmonary conges-
tion (11). In HF patients, PCO2 is inversely proportional to
ulmonary capillary wedge pressure (16). In 1 study, low-
ring wedge pressure by medical therapy and/or continuous
ositive airway pressure was associated with attenuation of
SA in patients with HF (12). More recently, we showed
hat overnight LFV is inversely proportional to PCO2
during sleep and directly related to the severity of CSA (17).
ccordingly, our findings provide novel evidence that noc-
urnal rostral fluid shift could predispose to CSA by
ncreasing respiratory drive, by lowering Rph and augment-
ng Vmin sufficiently to decrease PCO2 toward the apnea
threshold. These findings are consistent with those in dogs
and humans, in whom acute elevations in left atrial pressure
provoked hyperventilation and reduced PCO2 (16,46).
Despite their differing pathogenesis, men with HF can
have both OSA and CSA simultaneously, and the predom-
inant type can shift from obstructive to central in association
with a decrease in PCO2, an increase in circulation time,
and deterioration in cardiac function, or vice versa (20–22).
In a previous study, we observed a gradation from no sleep
apnea to OSA to CSA with progressively greater overnight
LFV shift (17). However, in the present study, we did not
find any difference in LFV between obstructive- and
central-dominant groups in response to LBPP. One possi-
ble explanation for this discrepancy is that acute fluid shift
induced by LBPP may consist mainly of intravascular fluid,
whereas overnight fluid shift probably consists of both
intravascular and extravascular components. Therefore, the
volume of fluid displaced from the legs by LBPP may be less
than the volume of fluid displaced overnight (17). In any
case, the volume of fluid shifted was sufficient to increase
Rph, reduce Vmin, and increase PtcCO2 in the obstructive-
ominant group, and to increase Vmin, and to reduce Rph
and PtcCO2 in the central-dominant group, probably due to
pulmonary irritant receptor stimulation. Another possibility
is that LBPP could have increased the venous return of
CO2, and if there was greater chemoreceptor reflex gain in
the central-dominant patients than in the obstructive-
dominant patients, there might have been greater augmen-
tation of ventilation in the former cohort as a consequence
(47). Although conceivable, we consider this unlikely, given
the small volume of fluid (260 ml) displaced as a result of
the acute application of LBPP, and therefore, the poten-
to
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March 19, 2013:1157–66 Fluid Shift and Pharyngeal Resistance in Heart Failuretially small increase of CO2 returned venously relative to the
otal cardiac output that might have occurred.
The differing respiratory response to LBPP in the
bstructive- and central-dominant groups may be related to
iffering basal cardiac loading conditions. For example, in
F patients, pulmonary capillary wedge pressure is higher
n those with CSA than in those with OSA or with no sleep
pnea (12). In keeping with that finding, we observed that
n the central-dominant group, the degree of mitral regur-
itation and right ventricular systolic pressure were much
igher than those in the obstructive-dominant group. In
ddition, NT-proBNP levels were more than 2-fold higher
han those in the obstructive-dominant group, with signif-
cant relationships between NT-proBNP level and indica-
ors of increased respiratory drive in response to LBPP.
T-proBNP is released mainly from the ventricular myo-
ardium in response to increased wall stress associated with
olume and pressure overload. Therefore, taken together,
reater mitral regurgitation, and higher right ventricular
ystolic pressure and NT-proBNP levels in the central-
ominant group are indicative of greater left ventricular
lling pressures, which suggests that these patients had
ore pulmonary congestion than those in the obstructive-
ominant group (48,49). Accordingly, for a similar fluid
hift from the legs into the heart, pulmonary congestion
ith stimulation of vagal irritant receptors, a consequent
ncrease in Vmin, and a decrease in PCO2 would more likely
ccur in patients with higher levels of left ventricular filling
ressures and NT-proBNP than in those with lower levels.
he significant inverse relationship between NT-proBNP
nd Rph during LBPP supports this concept. However,
ecause NT-proBNP levels were measured up to 3 months
efore the experiments, it is possible they could have
hanged by the time the experiments were performed;
herefore, the significant relationships between NT-
roBNP and Rph, Vmin, and PtcCO2 during LBPP
ay have altered. Nevertheless, because our subjects had to
e clinically stable and on stable medications for at least 3
onths, these relationships are liable to be meaningful.
tudy limitations. First, the experiments were conducted
uring wakefulness. It was not feasible for subjects to sleep
ninterrupted with inflation and deflation of the trousers
hile simultaneously measuring Rph with a tightly fitting
acemask. Therefore, the findings of the present study may
ot be reproduced exactly during sleep. However, responses
o fluid shift during sleep are unlikely to be qualitatively
ifferent, because we previously found strong relationships
n HF patients between spontaneous overnight fluid shift
nd the overnight increase in NC and AHI in obstructive-
ominant patients, and between spontaneous overnight
uid shift and PCO2 during sleep, as well as the AHI in
central-dominant patients (17). Second, because we studied
men only, our findings may not be applicable to women
with HF (24). Women were not studied because CSA is
rare in women with HF (1). Because we did not measure
activity of pharyngeal dilator muscles, we cannot be certainthat activation of these muscles caused the fall in Rph in
esponse to LBPP in the central-dominant group. Third, we
id not assess chemosensitivity; therefore, we could not
ssess the possible role of differing chemosensitivity on the
entilatory and Rph responses to LBPP. Further studies will
be required to determine whether LBPP has any effect on
genioglossus activity that might affect Rph or on venous
return of CO2 that might affect ventilation. Finally, due to
echnical limitations, we could not measure lung fluid
olume to determine whether fluid movement into the lungs
uring LBPP was related to increased Vmin and reduced Rph
in the central-dominant group.
Conclusions
The present study provides mechanistic evidence in favor of
the concept that nocturnal rostral fluid shift can contribute
to the pathogenesis of both OSA and CSA in men with
HF. Our data suggest that in those in whom rostral fluid
shift induces an increase in Rph, susceptibility to OSA will
ncrease, whereas in those in whom it induces an increase in
espiratory drive with reductions in Rph and PCO2, suscep-
tibility to CSA will increase. In the latter case, this suscep-
tibility appears to be related to greater left ventricular filling
pressure as evidenced by higher levels of NT-proBNP in the
central-dominant group that would predispose them to
pulmonary congestion in response to fluid loading. Our
findings also have therapeutic implications because they
raise the possibility that prevention of fluid accumulation in
the legs during the daytime or rostral fluid shift at night, by,
for example, cardiac rehabilitation (50), by wearing venous
compression stocking (7) or intensifying diuretic therapy
(45), may alleviate OSA or CSA in some men with HF.
Further studies are needed to test these possibilities.
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